OTC

Strength

17.5; 400; 10 mg/1; mg/1; mg/1

NDC

50991074001

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

3/18/2026

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M012

On Market Since

6/1/2019

Pharmacological Classes

Adrenergic alpha1-Agonists
Decreased Respiratory Secretion Viscosity
Expectorant
Increased Respiratory Secretions
Sigma-1 Agonist
Sigma-1 Receptor Agonists
Uncompetitive N-methyl-D-aspartate Receptor Antagonist
Uncompetitive NMDA Receptor Antagonists
alpha-1 Adrenergic Agonist

Price History

1W

0.0%

1M

0.0%

3M

-0.0%

6M

+0.2%

1Y

-0.3%

3Y

+3.4%

5Y

+3.4%

All

+1.9%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.